STOCK TITAN

Ventas (VTR) Stock News

VTR NYSE

Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.

Ventas, Inc. is an S&P 500 real estate investment trust with a healthcare and senior housing property portfolio in North America and the United Kingdom. News about VTR commonly covers quarterly results, senior housing operating portfolio performance, occupancy and RevPOR trends, net operating income, healthcare real estate investments, dividends and tax treatment of distributions.

Company updates also address investor presentations, earnings calls, capital allocation and portfolio categories that include senior housing communities, outpatient medical buildings, research centers and healthcare facilities.

Rhea-AI Summary

Ventas (NYSE: VTR) reported its Q3 2022 financial results, revealing a net income attributable to common stockholders of $0.00 per share, while Normalized FFO was $0.76, benefiting from $20 million in HHS grants. The company's same-store cash Net Operating Income (NOI) grew 4.8%, with the Senior Housing Operating Portfolio (SHOP) segment seeing a significant 13% increase. Ventas anticipates Q4 growth in SHOP cash NOI ranging from 15% to 21%, despite challenges from rising interest rates. The company maintains a strong balance sheet with $2.5 billion in liquidity and favorable debt maturity profiles.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.73%
Tags
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) will release its third quarter 2022 earnings on November 3, 2022, after the market closes. A conference call to discuss these results is scheduled for November 4, 2022, at 10:00 a.m. ET. Investors can participate via a dial-in number or through a live webcast available on www.ventasreit.com. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare and real estate sectors driven by the growing aging population.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
conferences earnings
-
Rhea-AI Summary

Ardent Health Services has appointed Carlene Callis as chief system integration and growth officer and Ben Jacobs as chief strategy and development officer. Callis will enhance care delivery and operational efficiency across the organization. With over 25 years in healthcare, she previously served at HCA. Jacobs, with nearly two decades of experience, will focus on strategic planning and expansion into new markets. Both leaders aim to strengthen Ardent’s mission of improving community healthcare access.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.42%
Tags
management
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced its participation in investor meetings at the Mizuho Healthcare REIT Conference on October 4, 2022. Written materials for the event will be available on the Company's website around the same date, and these will be archived for a limited time.

Ventas operates over 1,200 properties across the United States, Canada, and the United Kingdom, focusing on healthcare and real estate. The company’s strategy emphasizes diversification and financial strength, aimed at unlocking value in senior living and healthcare real estate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
conferences
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per share, payable on October 14, 2022, to stockholders recorded by the close of business on October 3, 2022.

As a leading real estate investment trust, Ventas operates in healthcare and real estate sectors with a portfolio of over 1,200 properties across the United States, Canada, and the United Kingdom. The company leverages its capital to enhance senior living, life science, and healthcare real estate.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
dividends earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
none
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced that CEO Debra A. Cafaro will receive the Women Corporate Directors (WCD) 2022 Visionary Award for Strategic Leadership. This award honors women leaders who promote diversity and long-term growth. Under Cafaro's leadership since 1999, Ventas's market capitalization surged from $200 million to $25 billion by 2022. The company is recognized for its commitment to environmental, social, and governance standards and for fostering a diverse workforce.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
none
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) has appointed Sumit Roy, President & CEO of Realty Income Corporation, to its Board of Directors effective October 1, 2022. Roy brings extensive experience in the REIT sector, having successfully led Realty Income’s growth and strategic initiatives. Concurrently, Robert D. Reed will retire from the Board after serving since 2008, effective at the 2023 Annual Meeting. Ventas's Board now comprises 12 directors, with 11 independent members, maintaining a diverse representation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
management
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) announced that its management will participate in investor meetings at the BofA Securities 2022 Global Real Estate Conference on September 13, 2022, at 1:25 p.m. Eastern Time. The presentation will be available via webcast on the Company’s website. Accompanying materials will be accessible on or about September 12, 2022. Ventas, a leader in healthcare and real estate, manages a portfolio of over 1,200 properties across the U.S., Canada, and the U.K., focusing on senior living and healthcare facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.25%
Tags
conferences
Rhea-AI Summary

Pure Health, a subsidiary of Alpha Dhabi Holding, has announced a $500 million minority equity investment in Ardent Health Services, a leading U.S. healthcare provider. This investment aims to enhance Pure Health's presence in the U.S. healthcare market. Ardent, ranked as the fourth largest private hospital operator in the U.S., operates 30 hospitals and 200+ care sites across six states. The investment is pending customary closing conditions and necessary U.S. regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
none

FAQ

What is the current stock price of Ventas (VTR)?

The current stock price of Ventas (VTR) is $84.6 as of June 12, 2026.

What is the market cap of Ventas (VTR)?

The market cap of Ventas (VTR) is approximately 40.8B.